Charles M. Winter's most recent trade in Janux Therapeutics Inc was a trade of 80,500 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Charles M. Winter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 80,500 | 80,500 | - | - | Stock option (right to buy) | |
| Janux Therapeutics Inc | Charles M. Winter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 23,000 | 77,288 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Winter M. Charles | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 111,000 | 111,000 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Charles M. Winter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |